Aggregating and disaggregating patients in clinical trials and their subgroup analyses.
Kent
David M
DM
Lindenauer
Peter K
PK
D000208:Acute Disease; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D003627:Data Interpretation, Statistical; D003692:Delayed-Action Preparations; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D051346:Mobility Limitation; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D003692:Delayed-Action Preparations; D017984:Enoxaparin